• Politics
  • Business
  • World
  • Science
  • Startup
  • Health
  • Travel
  • Economy
  • Top Story
Aryavarth News
  • Home
  • Politics
  • City News
  • Top Story
  • Editorial
No Result
View All Result
Aryavarth News
No Result
View All Result

Moderna announces 94.5% effectiveness in Covid vaccine

Covid-19 risk
430
SHARES
1.2k
VIEWS
Share on WhatsappShare on FacebookShare on TwitterShare on Telegram

New York, Nov 16 (Aryavarth) For the second time in the span of 10 days after the US elections, there’s a Covid-19 gamechanger on the horizon with US pharma giant Moderna announcing that its vaccine has shown more than 94.5 per cent effectiveness in preliminary data from the company’s ongoing study.

Pfizer Inc had announced 90 per cent efficacy exactly a week ago. Taken together, these two vaccines are firmly on course to seek emergency use authorisation from the US Food and Drug Administration if results hold out in final study results due soon.

“This is a pivotal moment in the development of our Covid-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible,” said Stephane Bancel, Chief Executive Officer at Moderna.

“All along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent the Covid-19 disease, including severe disease,” Bancel added.

Anthony Fauci from Trump’s coronavirus task force is optimistic that these early vaccines will change the course of “everything we do” over the next few months.

Pfizer’s final results are due in the third week of November – around the time of the Thanksgiving holiday.

Covid cases in the US crossed 11 million by November 15, with the latest 1 million coming in a week. The country’s death toll is the world’s highest – more than 246,000 at last count.

Roughly 20 million people could be vaccinated against the coronavirus in December, the chief of the Donald Trump administration’s vaccine coordination programme has indicated. Anywhere from 25 to 30 million people could be vaccinated each month after that.

The US is working with a portfolio of six vaccines, using three different platform technologies and two candidates from each platform: Messenger RNA, live viral vectors and recombinant protein.

Pfizer and Moderna’s vaccines use the messenger RNA platform, Johnson and Johnson and AstraZeneca in partnership with Oxford University are on the live vector path while Novavax and Sanofi/GlaxoSmithKline are building out their vaccine candidates on the recombinant protein platform.

The study, known as the COVE study, enrolled more than 30,000 participants in the US and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services.

The company said it remains on track to manufacture 500 million to 1 billion doses globally in 2021.

Tags: Covid19
SendShare172Tweet108Share
    • Trending
    • Comments
    • Latest
    Guru Gobinds son bricked alive and then killed

    Crores of Hindus Were killed by Islamic Rulers: Hindu Genocide Not Recorded In History

    August 10, 2020
    Pakistan Behind removal of Punjab CM:  Dr Subramanian Swamy

    Pakistan Behind removal of Punjab CM: Dr Subramanian Swamy

    September 20, 2021
    Lenovo under US scanner for spying for China

    Lenovo’s Links to China Government Under Scrutiny For Spying

    July 22, 2020
    Republic TV and R Bharat get a clean chit in Television Rating Points (TRP) scam

    Republic TV and R Bharat get a clean chit in Television Rating Points (TRP) scam

    3
    Today’s Newspaper – 17 August 2022

    Today’s Newspaper – 17 August 2022

    2
    Today’s Newspaper – 10 August 2022

    Today’s Newspaper – 10 August 2022

    1
    WHO and the Ministry of Ayush to host the first-ever Global Summit on Traditional Medicine

    Only Positive Step In G20 Summit Was The Admission Of African Union As A Permanent Member

    September 15, 2023
    Singapore invents tech to detect COVID-19 virus the air

    India Rises as Global Leader in Medical Textiles Amid COVID-19 Pandemic

    September 15, 2023
    Improving Healthcare for All

    CSIR-NIScPR and KAMP Host Workshop to Boost Science Communication in India

    September 15, 2023
    Aryavarth News

    Copyright © 2022 Aryavarth Publication Pvt Ltd.

    Navigate Site

    • About
    • Advertise
    • Privacy & Policy
    • Contact

    Follow Us

    No Result
    View All Result
    • Politics
    • Business
    • World
    • Science
    • Startup
    • Health
    • Travel
    • Economy
    • Top Story

    Copyright © 2022 Aryavarth Publication Pvt Ltd.

    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.